Global Cord Blood Corp
OTC:CORBF
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.2
1.75
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| HK |
|
Global Cord Blood Corp
OTC:CORBF
|
115.5m USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
101.5B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
72.6B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
62B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.6B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
21.3B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.8B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.2B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.1B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.5B EUR |
Loading...
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
11.2B AUD |
Loading...
|
Market Distribution
| Min | -239 513 300% |
| 30th Percentile | -12.9% |
| Median | 0.5% |
| 70th Percentile | 5.3% |
| Max | 203 056% |
Other Profitability Ratios
Global Cord Blood Corp
Glance View
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,215 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
Over the last 3 years, Global Cord Blood Corp’s Net Margin has increased from 198% to 280.7%. During this period, it reached a low of 198% on Mar 3, 2019 and a high of 287.2% on Mar 31, 2021.